There is a strong relationship between levels of violence and modifiable factors in a country such as an concentrated (regional) poverty, income and gender inequality, the harmful use of alcohol, and the absence of safe, stable, and nurturing relationships between children and parents. Strategies addressing the underlying causes of violence can be relatively effective in preventing violence, although mental and physical health and individual responses, personalities, etc. have always been decisive factors in the formation of these behaviors. Types
The World Health Organization divides violence into three broad categories:
self-directed violence
interpersonal violence
collective violenceThis initial categorization differentiates between violence that a person inflicts upon themself, violence inflicted by another individual or by a small group of individuals, and violence inflicted by larger groups such as states, organized political groups, militia groups and terrorist organizations. Alternatively, violence can primarily be classified as either instrumental or reactive / hostile. Self-directed
Self-directed violence is subdivided into suicidal behaviour and self-abuse. The former includes suicidal thoughts, attempted suicides—also called para suicide or deliberate self-injury in some countries—and suicide itself. Self-abuse, in contrast, includes acts such as self-mutilation. Collective
Unlike the other two broad categories, the subcategories of collective violence suggest possible motives for violence committed by larger groups of individuals or by states. Collective violence that is committed to advance a particular social agenda includes, for example, crimes of hate committed by organized groups, terrorist acts and mob violence. Political violence includes war and related violent conflicts, state violence and similar acts carried out by armed groups.
A clinical trial of vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma was negative in a prospective, randomised, double-blind, multicentre phase 2 trial. References
External links
"Vandetanib". Drug Information Portal. U.S. National Library of Medicine.